搜索临床试验以:rhIL-15
总计1122个结果
-
Hanmi Pharmaceutical Company Limited完全的
-
Universitaire Ziekenhuizen KU LeuvenAllergan未知
-
InnovaGyn, Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)招聘中
-
National Cancer Institute (NCI)主动,不招人晚期膀胱尿路上皮癌 | 晚期输尿管尿路上皮癌 | 转移性膀胱尿路上皮癌 | 转移性肾盂尿路上皮癌 | 转移性输尿管尿路上皮癌 | 转移性尿道尿路上皮癌 | 转移性尿路上皮癌 | 复发性膀胱尿路上皮癌 | 复发性肾盂尿路上皮癌 | 复发性输尿管尿路上皮癌 | 复发性尿道尿路上皮癌 | III 期膀胱癌 AJCC v8 | III 期肾盂癌 AJCC v8 | III 期输尿管癌 AJCC v8 | III 期尿道癌 AJCC v8 | IV 期膀胱癌 AJCC v8 | IV 期肾盂癌 AJCC v8 | IV 期输尿管癌 AJCC v8 | IV 期尿道癌 AJCC v8 | IVA 期膀胱癌 AJCC v8 | IVB 期膀胱癌 AJCC v8 | 不可切除的膀胱尿路上皮癌 | 不可切除的肾盂尿路上皮癌 | ...美国
-
Jordi Gol i Gurina FoundationSpanish Clinical Research Network - SCReN完全的
-
Futura Medical Developments Ltd.Parexel完全的
-
Royal Marsden NHS Foundation TrustHoffmann-La Roche; Professor Cunningham's Clinical Research Fund完全的
-
McGill University Health Centre/Research Institute...终止
-
National Institute of Allergy and Infectious Diseases...University of Rochester完全的
-
Boehringer IngelheimEli Lilly and Company完全的
-
The University of Texas Health Science Center,...Robert Cizik Eye Clinic完全的
-
University of TorontoSunnybrook Health Sciences Centre; Canadian Institutes of Health Research (CIHR); The Physicians... 和其他合作者完全的
-
Seoul National University Hospital未知
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人造血和淋巴细胞肿瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 复发性原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 难治性原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 复发性高级 B 细胞淋巴瘤 | 复发性转化滤泡性淋巴瘤至弥漫性大 B 细胞淋巴瘤 | 难治性高级 B 细胞淋巴瘤 | 难治性转化滤泡性淋巴瘤至弥漫性大 B 细胞淋巴瘤美国
-
GlaxoSmithKline完全的
-
Instituto Nacional de Cardiologia Ignacio Chavez招聘中
-
Universiti Kebangsaan Malaysia Medical CentreInstitue of Microengineering and Nanoelectronics (IMEN), Universiti Kebangsaan Malaysia; Universiti...完全的
-
Memorial Sloan Kettering Cancer Center主动,不招人
-
Nanfang Hospital of Southern Medical University未知
-
Eli Lilly and CompanyARMO BioSciences主动,不招人黑色素瘤 | 肾细胞癌 | 乳腺癌 | 卵巢癌 | 前列腺癌 | 非小细胞肺癌 | 实体瘤 | 大肠癌 | 胰腺癌美国
-
The University of Hong KongLondon School of Hygiene and Tropical Medicine; Nagasaki University邀请报名
-
GlaxoSmithKlineMedicines for Malaria Venture完全的